Table 1.
Group | G (bpm/mmHg) | P1 (Δbpm) | P2 (Δbpm) | HR range (bpm) | BP50 (ΔmmHg) | Slope Bradycardia (bpm/mmHg) | Slope Tachycardia (bpm/mmHg) |
---|---|---|---|---|---|---|---|
Vehicle | |||||||
Control | -2.1 ± 0.2 | -74 ± 5 | 134 ± 8 | 202 ± 6 | -1.3 ± 5 | -2.3 ± 0.2 | -3.2 ± 0.5 |
RRS | -1.2 ± 0.2∗ | -59 ± 6 | 94 ± 8∗ | 157 ± 5∗ | -4.2 ± 4 | -1.7 ± 0.2 | -2.6 ± 0.4 |
CVS | -1.2 ± 0.2∗ | -66 ± 6 | 96 ± 9∗ | 164 ± 12 | -2.1 ± 3 | -2.4 ± 0.3 | -2.5 ± 0.5 |
Losartan | |||||||
Control | -2.3 ± 0.3 | -78 ± 9 | 109 ± 12 | 187 ± 11 | 1.0 ± 3 | -1.9 ± 0.3 | -2.7 ± 0.6 |
RRS | -2.6 ± 0.2# | -89 ± 9 | 102 ± 11 | 199 ± 8# | 0.0 ± 2 | -2.6 ± 0.4 | -2.0 ± 0.6 |
CVS | -1.8 ± 0.2# | -66 ± 9 | 115 ± 12 | 178 ± 18 | -5.4 ± 2 | -2.3 ± 0.3 | -3.0 ± 0.5 |
Values are mean ± SEM (n = 6: vehicle control, losartan control; n = 7: losartan CVS; n = 8: vehicle RRS, vehicle CVS, losartan RRS).
∗P < 0.05 versus control group within same condition, #P < 0.05 versus respective group vehicle. Two-way ANOVA followed by Bonferroni’s post hoc test.